To further validate the diagnostic efficiency of MPO, PRTN3, and CTNND1 for AHO patients, we plotted ROC curves, where the AUC for MPO, PRTN3, and CTNND1 was 0.9803, 0.9767, and 0.8832, respectively (Figures 5D–F). This evidence concerns the gene PRTN3 and pseudohypoparathyroidism type 1A.